OncoAssign
OncoAssign uses AI-driven biomarkers to help oncologists pick the best cancer treatment upfront. It runs RNA-based diagnostics and companion diagnostics built on thousands of patient samples and extensive colorectal cancer datasets. The platform is a precision oncology solution for clinicians, powered by AI, RNA-based diagnostics, and validated biomarkers to predict the most beneficial therapies. This approach aims to improve treatment accuracy, reduce toxicity, and scale across oncology practices.
OncoAssign
OncoAssign uses AI-driven biomarkers to help oncologists pick the best cancer treatment upfront. It runs RNA-based diagnostics and companion diagnostics built on thousands of patient samples and extensive colorectal cancer datasets. The platform is a precision oncology solution for clinicians, powered by AI, RNA-based diagnostics, and validated biomarkers to predict the most beneficial therapies. This approach aims to improve treatment accuracy, reduce toxicity, and scale across oncology practices.